These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24551674)
1. Anti-mutagenicity Effects of Vitamin E on Oncology and Non-oncology Hospital Nurses by Ames Assay. Rezaei-Basiri M; Rezazadeh H; Aswadi-Kermani I; Ghazi-Khansari M J Clin Diagn Res; 2013 Dec; 7(12):2917-21. PubMed ID: 24551674 [TBL] [Abstract][Full Text] [Related]
2. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs. Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554 [TBL] [Abstract][Full Text] [Related]
3. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures. Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994 [TBL] [Abstract][Full Text] [Related]
4. Handling of cytostatic drugs and urine mutagenesis. Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590 [TBL] [Abstract][Full Text] [Related]
5. Antimutagenic effects of vitamin E on oncology and non oncology hospital nurses by comet assay. Rezaei-Basiri M; Rezazadeh H; Asvadi-Kermani I; Davoodi A; Eghbal MA; Golchin M; Sarmad M Drug Res (Stuttg); 2014 Jul; 64(7):337-42. PubMed ID: 24357140 [TBL] [Abstract][Full Text] [Related]
6. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials. DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking. Bos RP; Leenaars AO; Theuws JL; Henderson PT Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139 [TBL] [Abstract][Full Text] [Related]
8. The correlation between antimutagenic activity and total phenolic content of extracts of 31 plant species with high antioxidant activity. Makhafola TJ; Elgorashi EE; McGaw LJ; Verschaeve L; Eloff JN BMC Complement Altern Med; 2016 Nov; 16(1):490. PubMed ID: 27899116 [TBL] [Abstract][Full Text] [Related]
9. Occupational exposure to anticancer drug--potential and real hazards. Sorsa M; Hemminki K; Vainio H Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080 [TBL] [Abstract][Full Text] [Related]
10. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs. Barale R; Sozzi G; Toniolo P; Borghi O; Reali D; Loprieno N; Della Porta G Mutat Res; 1985; 157(2-3):235-40. PubMed ID: 4022044 [TBL] [Abstract][Full Text] [Related]
11. Mutagenicity in urine from nurses handling cytostatic agents. Benhamou S; Callais F; Sancho-Garnier H; Min S; Courtois YA; Festy B Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1489-93. PubMed ID: 3595674 [TBL] [Abstract][Full Text] [Related]
12. Mutagenicity testing of protein-containing and biological samples using the Ames/Salmonella plate incorporation test and the fluctuation test. Nylund L; Einistö P Mutat Res; 1992 Dec; 272(3):205-14. PubMed ID: 1281266 [TBL] [Abstract][Full Text] [Related]
13. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure. Doolittle DJ; Lee DA; Rahn CA Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496 [TBL] [Abstract][Full Text] [Related]
14. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. Rekhadevi PV; Sailaja N; Chandrasekhar M; Mahboob M; Rahman MF; Grover P Mutagenesis; 2007 Nov; 22(6):395-401. PubMed ID: 17855733 [TBL] [Abstract][Full Text] [Related]
15. A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project. Moretti M; Bonfiglioli R; Feretti D; Pavanello S; Mussi F; Grollino MG; Villarini M; Barbieri A; Ceretti E; Carrieri M; Buschini A; Appolloni M; Dominici L; Sabatini L; Gelatti U; Bartolucci GB; Poli P; Stronati L; Mastrangelo G; Monarca S BMC Public Health; 2011 Mar; 11():195. PubMed ID: 21450074 [TBL] [Abstract][Full Text] [Related]
16. Can we detect mutagenic activity of urinary sediment by the Ames test? Bubak A; Mielzyńska D; Siwińska E Int J Occup Med Environ Health; 1997; 10(1):47-54. PubMed ID: 9187046 [TBL] [Abstract][Full Text] [Related]
17. Investigating the mutagenic effects of three commonly used pulpotomy agents using the ames test. Samiei M; Asgary S; Farajzadeh M; Bargahi N; Abdolrahimi M; Kananizadeh U; Dastmalchi S Adv Pharm Bull; 2015 Mar; 5(1):121-5. PubMed ID: 25789229 [TBL] [Abstract][Full Text] [Related]
18. The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100. Thorne D; Crooks I; Hollings M; Seymour A; Meredith C; Gaca M Mutat Res Genet Toxicol Environ Mutagen; 2016 Dec; 812():29-38. PubMed ID: 27908385 [TBL] [Abstract][Full Text] [Related]
19. Mutagenic activity of overnight urine from healthy non-smoking subjects. Pavanello S; Lupi S; Pulliero A; Gregorio P; Saia BO; Clonfero E Environ Mol Mutagen; 2007 Mar; 48(2):143-50. PubMed ID: 17295305 [TBL] [Abstract][Full Text] [Related]
20. Mutagenicity assessment of environmental contaminations in a hospital centralized reconstitution unit. Chouquet T; Acramel A; Sauvageon H; Plé A; Jourdan N; Madelaine I; Faure P; Mourah S; Goldwirt L Ecotoxicol Environ Saf; 2018 Dec; 165():174-181. PubMed ID: 30195999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]